IL162456A0 - A novel polymorph of sertraline hydrochloride and composition containing thereof, novel methods for preparation of sertraline hydrochlor - Google Patents

A novel polymorph of sertraline hydrochloride and composition containing thereof, novel methods for preparation of sertraline hydrochlor

Info

Publication number
IL162456A0
IL162456A0 IL16245601A IL16245601A IL162456A0 IL 162456 A0 IL162456 A0 IL 162456A0 IL 16245601 A IL16245601 A IL 16245601A IL 16245601 A IL16245601 A IL 16245601A IL 162456 A0 IL162456 A0 IL 162456A0
Authority
IL
Israel
Prior art keywords
sertraline
novel
hydrochlor
preparation
composition containing
Prior art date
Application number
IL16245601A
Other languages
English (en)
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23782424&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL162456(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of IL162456A0 publication Critical patent/IL162456A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/82—Purification; Separation; Stabilisation; Use of additives
    • C07C209/84—Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
    • C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL16245601A 1999-11-24 2001-12-13 A novel polymorph of sertraline hydrochloride and composition containing thereof, novel methods for preparation of sertraline hydrochlor IL162456A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/448,985 US6500987B1 (en) 1998-11-27 1999-11-24 Sertraline hydrochloride polymorphs
PCT/US2001/047546 WO2003051818A1 (en) 1999-11-24 2001-12-13 A novel polymorph of sertraline hydrochloride and composition containing thereof, novel methods for preparation of sertraline hydrochloride polymorphs and amorphous form

Publications (1)

Publication Number Publication Date
IL162456A0 true IL162456A0 (en) 2005-11-20

Family

ID=23782424

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16245601A IL162456A0 (en) 1999-11-24 2001-12-13 A novel polymorph of sertraline hydrochloride and composition containing thereof, novel methods for preparation of sertraline hydrochlor

Country Status (14)

Country Link
US (6) US6500987B1 (xx)
EP (1) EP1463711A4 (xx)
JP (1) JP2005511780A (xx)
KR (1) KR20040074075A (xx)
CN (1) CN1589256A (xx)
AU (1) AU2002228933A1 (xx)
CA (1) CA2469108A1 (xx)
HR (1) HRP20040630A2 (xx)
HU (1) HUP0402622A2 (xx)
IL (1) IL162456A0 (xx)
IS (1) IS7308A (xx)
MX (1) MXPA04005763A (xx)
NO (1) NO20042932L (xx)
WO (1) WO2003051818A1 (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500987B1 (en) * 1998-11-27 2002-12-31 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride polymorphs
TWI260315B (en) 1999-10-29 2006-08-21 Ciba Sc Holding Ag Polymorphic forms of sertraline hydrochloride
JP4057295B2 (ja) 1999-12-21 2008-03-05 テバ ファーマシューティカル インダストリーズ リミティド 新規塩酸セルトラリン多形体、それらを調製するための方法、それらを含有する組成物およびそれらを用いる方法
IL151691A0 (en) * 2000-03-14 2003-04-10 Teva Pharma Novel process for preparing (+)-cis-sertraline
IN192343B (xx) * 2000-05-26 2004-04-10 Ranbaxy Lab Ltd
EP1397343A1 (en) * 2001-05-31 2004-03-17 Orion Corporation Fermion Process for preparing sertraline hydrochloride polymorphic form ii
CA2483569A1 (en) * 2002-04-29 2003-11-13 Tamar Nidam Process for preparation of polymorphic form ii of sertraline hydrochloride, pharmaceutical formulations and methods of administration thereof
EP1558561A1 (en) * 2002-11-07 2005-08-03 Torrent Pharmaceuticals Ltd Process for preparation of polymorphic form of sertraline hydrochloride
JP2007502329A (ja) * 2003-05-23 2007-02-08 トランスフォーム・ファーマシューティカルズ・インコーポレイテッド セルトラリン組成物
US7173153B2 (en) * 2003-07-15 2007-02-06 Recordati Industria Chimica E. Farmaceutica S.P.A. Sertraline hydrochloride form II and methods for the preparation thereof
US7189876B2 (en) * 2003-07-15 2007-03-13 Recordati Industria Chimica E Farmaceutica S.P.A. Methods for preparing sertraline hydrochloride polymorphs
EP1660432A2 (en) * 2003-09-05 2006-05-31 Teva Pharmaceutical Industries Limited A recycling process for preparing sertraline
CA2544684A1 (en) * 2003-11-04 2005-05-26 Cipla Limited Process for the preparation of polymorphs of selective serotonin reuptake inhibitor
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US7345201B2 (en) * 2005-02-23 2008-03-18 Teva Pharmaceutical Industries, Ltd. Processes for preparing sertraline
GB0507090D0 (en) * 2005-04-07 2005-05-11 Sandoz Ag Process for preparing polymorphic form ll of sertraline hydrochloride
US20070100165A1 (en) * 2005-06-09 2007-05-03 Ronen Borochovitz Process for preparation of sertraline hydrochloride form I
DE602007003024D1 (de) * 2006-06-27 2009-12-10 Sandoz Ag Neues verfahren zur salzherstellung
US20060257475A1 (en) * 2006-08-17 2006-11-16 Boehringer Ingelheim International Gmbh Stable Sertraline Hydrochloride Formulation and Method
CA2594198A1 (en) * 2007-07-20 2009-01-20 Apotex Pharmachem Inc. A novel process for the preparation of sertraline hydrochloride form ii
MX2021001169A (es) 2013-11-15 2023-02-10 Akebia Therapeutics Inc Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acético, composiciones, y usos de las mismas.
WO2016171254A1 (ja) * 2015-04-22 2016-10-27 日本ケミファ株式会社 ２－［３－シアノ－４－（２－メチルプロポキシ）フェニル］－４－メチルチアゾール－５－カルボン酸の結晶、その製造方法、及びそれらの利用
CN105061217A (zh) * 2015-06-30 2015-11-18 徐静 枸橼酸舍曲林的2种晶型及其制备方法
CN112552188B (zh) * 2020-12-17 2023-07-28 山西仟源医药集团股份有限公司 盐酸舍曲林晶型i的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US5082970A (en) 1991-03-06 1992-01-21 Pfizer Inc. Process for recycling amine isomer
GB9114947D0 (en) 1991-07-11 1991-08-28 Pfizer Ltd Process for preparing sertraline
US5248699A (en) 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5734083A (en) 1996-05-17 1998-03-31 Torcan Chemical Ltd. Sertraline polymorph
ES2217748T3 (es) 1998-03-18 2004-11-01 Ciba Specialty Chemicals Holding Inc. Procedimiento para la hidrogenacin catalitica cis-selectiva de ciclohexilidenaminas.
JP2000026378A (ja) 1998-07-03 2000-01-25 Sumika Fine Chemicals Co Ltd 塩酸セルトラリンの製法
JP2000026379A (ja) 1998-07-08 2000-01-25 Sumika Fine Chemicals Co Ltd 塩酸セルトラリンメタノール和物および塩酸セルトラリンエタノール和物、ならびにそれらの製法
ES2255320T3 (es) * 1998-11-27 2006-06-16 Teva Pharmaceutical Industries Ltd. Forma v clorhidrato de sertralina.
US6500987B1 (en) * 1998-11-27 2002-12-31 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride polymorphs
TWI260315B (en) * 1999-10-29 2006-08-21 Ciba Sc Holding Ag Polymorphic forms of sertraline hydrochloride
JP4057295B2 (ja) * 1999-12-21 2008-03-05 テバ ファーマシューティカル インダストリーズ リミティド 新規塩酸セルトラリン多形体、それらを調製するための方法、それらを含有する組成物およびそれらを用いる方法
IN192343B (xx) 2000-05-26 2004-04-10 Ranbaxy Lab Ltd

Also Published As

Publication number Publication date
NO20042932L (no) 2004-07-12
US20040220280A1 (en) 2004-11-04
US20030055112A1 (en) 2003-03-20
US6500987B1 (en) 2002-12-31
KR20040074075A (ko) 2004-08-21
CN1589256A (zh) 2005-03-02
US7022881B2 (en) 2006-04-04
MXPA04005763A (es) 2005-03-31
CA2469108A1 (en) 2003-06-26
EP1463711A1 (en) 2004-10-06
US20080176949A1 (en) 2008-07-24
WO2003051818A1 (en) 2003-06-26
US20060241189A1 (en) 2006-10-26
AU2002228933A1 (en) 2003-06-30
EP1463711A4 (en) 2007-12-19
HUP0402622A2 (hu) 2005-03-29
US6600073B1 (en) 2003-07-29
IS7308A (is) 2004-06-11
HRP20040630A2 (en) 2004-10-31
JP2005511780A (ja) 2005-04-28

Similar Documents

Publication Publication Date Title
IL162456A0 (en) A novel polymorph of sertraline hydrochloride and composition containing thereof, novel methods for preparation of sertraline hydrochlor
HUP0203559A3 (en) Polymorphic forms of sertraline hydrochloride, process for their preparation and pharmaceutical compositions containing them
HUP0204010A3 (en) Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and their use
AU4465200A (en) Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them
IL196287A0 (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof
AU2953699A (en) Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them
HUP0002843A3 (en) New betha-carboline compounds, a process for their preparation and pharmaceutical compositions containing them
HK1042698B (zh) 新的二苯脲化合物、其製備方法和含有該化合物的藥物組合物
HUP0105108A3 (en) Amide compounds, process for their preparation and pharmaceutical compositions containing them
IL155966A0 (en) Benzothiophene derivative compounds, process of preparation and use thereof
HUP0400208A3 (en) N-formyl hydroxylamine compounds, process for their preparation and pharmaceutical compositions containing them
HUP0000140A3 (en) Tramadol containing retarded pharmaceutical compositions, having storage-stabiled release and process for producing them
AP2004002989A0 (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation.
EP1289928A4 (en) NEW AMORPHOUS FORM OF SERTRALINE HYDROCHLORIDE
HK1039117B (zh) 新的哌啶-4-磺酰胺化合物、其製備方法和含有它們的藥物組合物
IL164903A0 (en) Processes for preparation of polymorphic form II of sertraline hydrochloride, pharmaceutical formulations and methods of administration thereof
HUP0700037A2 (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
HUP0104272A3 (en) New cyclobutendione compounds, a process for their preparation and pharmaceutical compositions containing them
HUP0202322A2 (en) A substantially crystalline form of melagatran, process for obtaining it, pharmaceutical composition containing thereof and its use
IL162255A0 (en) Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
HUP0203842A3 (en) Controlled release pharmaceutical composition containing tramadol hydrochloride and method for its preparation
PL340237A1 (en) Novel intermediate compounds, method of obtaining cis-1-(2-[-(6-metoxy-2-phenyl-1,2,3,4-tetrahydronaphtalen-1-nyl)phenoxy]ethyl) pyrolydine and method of obtaining intermediate compounds
AU2001235970A1 (en) Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation
HUP0000308A2 (en) New cyano-indole serotonin-reuptake inhibitor compounds, a process for their preparation and pharmaceutical compositions containing them
PL372137A1 (en) A novel polymorph of sertraline hydrochloride and composition containing thereof, novel methods for preparation of sertraline hydrochloride polymorphs and amorphous form